|
ZBTB11 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.877900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.282300E-03 |
| Normal-vs-Stage2 |
3.867000E-01 |
| Normal-vs-Stage3 |
3.115000E-01 |
| Normal-vs-Stage4 |
6.391000E-01 |
| Stage1-vs-Stage2 |
5.868200E-01 |
| Stage1-vs-Stage3 |
5.577600E-01 |
| Stage1-vs-Stage4 |
6.101000E-01 |
| Stage2-vs-Stage3 |
9.769600E-01 |
| Stage2-vs-Stage4 |
9.216200E-01 |
| Stage3-vs-Stage4 |
9.006400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.064400E-02 |
| Normal-vs-AfricanAmerican |
1.808240E-02 |
| Normal-vs-Asian |
5.874800E-01 |
| Caucasian-vs-AfricanAmerican |
4.066600E-01 |
| Caucasian-vs-Asian |
9.903400E-01 |
| AfricanAmerican-vs-Asian |
7.287800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.016900E-03 |
| Normal-vs-Female |
7.803000E-01 |
| Male-vs-Female |
1.393630E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.784100E-02 |
| Normal-vs-Extreme_Weight |
6.982900E-04 |
| Normal-vs-Obese |
3.502400E-01 |
| Normal-vs-Extreme_Obese |
3.079400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.006800E-01 |
| Normal_Weight-vs-Obese |
4.116200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.115800E-01 |
| Extreme_Weight-vs-Obese |
5.181800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.142800E-01 |
| Obese-vs-Extreme_Obese |
5.411200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.004200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.373600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.037000E-03 |
| Normal-vs-Age(81-100Yrs) |
8.602500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.342200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.777800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.778100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.011800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.042400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.245400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.055770E-01 |
| Normal-VS-Type2 PRCC |
1.102370E-03 |
| Normal-VS-KIRP CIMP |
4.322200E-01 |
| Normal-VS-Unclassified PRCC |
8.210400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.397600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.640040E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.960600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.956200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.349900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.446200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.570040E-04 |
| Normal-vs-N1 |
4.771600E-01 |
| Normal-vs-N2 |
5.236200E-01 |
| N0-vs-N1 |
1.090310E-02 |
| N0-vs-N2 |
7.790400E-01 |
| N1-vs-N2 |
3.552800E-01 |
|
|
